Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 3/20 | 0.36 |
| ▸ | ESR2 | Q92731 | 3/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | PDK2 | Q15119 | 5/20 | 0.35 |
| ▸ | ACMSD | Q8TDX5 | 1/20 | 0.33 |
| ▸ | GSTP1 | P09211 | 1/20 | 0.33 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.32 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.32 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.32 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.32 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.32 |
| ▸ | LPL | P06858 | 1/20 | 0.32 |
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.32 |
| ▸ | CA1 | P00915 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24647562 | 1.00 | ESR1 (0.36) | ESR1ESR2KDM4EMEN1LMNA | |
| SCHEMBL17033063 | 0.99 | ESR1 (0.36) | ESR1ESR2KDM4EMEN1LMNA | |
| SCHEMBL21923839 | 0.98 | PDK2 (0.36) | ESR1ESR2KDM4EMEN1LMNA | |
| SCHEMBL23137670 | 0.97 | PDK2 (0.37) | ESR1ESR2KDM4EMEN1LMNA | |
| SCHEMBL24255731 | 0.97 | ESR1 (0.36) | ESR1ESR2KDM4EMEN1LMNA | |
| SCHEMBL24687347 | 0.97 | ESR1 (0.36) | ESR1ESR2KDM4EMEN1LMNA | |
| SCHEMBL24255799 | 0.97 | PDK2 (0.37) | ESR1ESR2KDM4EMEN1LMNA | |
| SCHEMBL17903072 | 0.97 | MEN1 (0.38) | ESR1ESR2KDM4EMEN1LMNA | |
| SCHEMBL21392510 | 0.96 | KDM4E (0.35) | ESR1ESR2KDM4EMEN1LMNA | |
| SCHEMBL24646665 | 0.96 | KDM4E (0.35) | ESR1ESR2KDM4EMEN1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11877509-B2 | Organic light-emitting element | LG CHEM, LTD. | 2024-01-16 | — | — | US | disclosed |
| US-20230210002-A1 | COMPOSITION, AND ORGANIC ELECTROLUMINESCENCE DEVICE | IDEMITSU KOSAN CO.,LTD. (JP) | 2023-06-29 | — | — | US | disclosed |
| US-20230210002-A1 | COMPOSITION, AND ORGANIC ELECTROLUMINESCENCE DEVICE | IDEMITSU KOSAN CO.,LTD. (JP) | 2023-06-29 | — | — | US | disclosed |
| US-11575087-B1 | Organic electroluminescence device, light emitting device, organic electroluminescence display device and electronic device | IDEMITSU KOSAN CO., LTD. (JP) | 2023-02-07 | — | — | US | disclosed |
| US-20230036664-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE, LIGHT EMITTING DEVICE, ORGANIC ELECTROLUMINESCENCE DISPLAY DEVICE AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO.,LTD. (JP) | 2023-02-02 | — | — | US | disclosed |
| US-11069861-B2 | Mixture, organic electroluminescence device and electronic equipment | IDEMITSU KOSAN CO., LTD. (JP) | 2021-07-20 | — | — | US | disclosed |
| US-20210043850-A1 | MIXTURE, ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC EQUIPMENT | IDEMITSU KOSAN CO.,LTD. (JP) | 2021-02-11 | — | — | US | disclosed |
| US-20150228899-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT | IDEMITSU KOSAN CO., LTD. (JP) | 2015-08-13 | — | — | US | disclosed |
| US-20150228899-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT | IDEMITSU KOSAN CO., LTD. (JP) | 2015-08-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11877509-B2 | Organic light-emitting element | CRY1, CRY2, NR2E3 | ESR1 4/4885ESR2 33/4885KDM4E 1903/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.